Loading...
XNYSFMC
Market cap6.28bUSD
Jan 08, Last price  
50.31USD
1D
-1.60%
1Q
-16.68%
Jan 2017
-11.05%
Name

FMC Corp

Chart & Performance

D1W1MN
XNYS:FMC chart
P/E
4.76
P/S
1.40
EPS
10.56
Div Yield, %
4.63%
Shrs. gr., 5y
-1.57%
Rev. gr., 5y
0.92%
Revenues
4.49b
-22.67%
2,051,200,0002,150,200,0002,347,000,0002,632,900,0003,115,300,0002,826,200,0003,116,300,0003,377,900,0003,748,300,0003,874,800,0003,258,700,0003,276,500,0003,282,400,0002,878,600,0004,285,300,0004,609,800,0004,642,100,0005,045,200,0005,802,300,0004,486,800,000
Net income
1.32b
+79.06%
160,200,000116,600,000132,000,000132,400,000304,600,000228,500,000172,500,000365,900,000416,200,000293,900,000307,500,000489,000,000209,100,000535,800,000502,100,000477,400,000552,400,000739,600,000736,500,0001,318,800,000
CFO
-386m
L
210,400,000217,000,000264,000,000269,600,000307,600,000301,500,000354,500,000381,300,000359,700,000328,700,000373,700,000-357,700,000497,800,000335,500,000368,400,000488,500,000647,800,000820,100,000582,400,000-386,400,000
Dividend
Sep 30, 20240.58 USD/sh
Earnings
Feb 03, 2025

Profile

FMC Corporation, an agricultural sciences company, provides crop protection, plant health, and professional pest and turf management products. It develops, markets, and sells crop protection chemicals that include insecticides, herbicides, and fungicides; and biologicals, crop nutrition, and seed treatment products, which are used in agriculture to enhance crop yield and quality by controlling a range of insects, weeds, and diseases, as well as in non-agricultural markets for pest control. The company markets its products through its own sales organization and through alliance partners, independent distributors, and sales representatives. It operates in North America, Latin America, Europe, the Middle East, Africa, and Asia. FMC Corporation was founded in 1883 and is headquartered in Philadelphia, Pennsylvania.
IPO date
Sep 10, 1948
Employees
6,600
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
4,486,800
-22.67%
5,802,300
15.01%
Cost of revenue
3,737,100
4,564,900
Unusual Expense (Income)
NOPBT
749,700
1,237,400
NOPBT Margin
16.71%
21.33%
Operating Taxes
(1,119,300)
145,200
Tax Rate
11.73%
NOPAT
1,869,000
1,092,200
Net income
1,318,800
79.06%
736,500
-0.42%
Dividends
(290,500)
(267,500)
Dividend yield
3.67%
1.69%
Proceeds from repurchase of equity
(75,900)
(99,500)
BB yield
0.96%
0.63%
Debt
Debt current
958,400
540,800
Long-term debt
3,294,400
2,883,800
Deferred revenue
10,100
Other long-term liabilities
803,300
906,000
Net debt
3,930,600
2,838,100
Cash flow
Cash from operating activities
(386,400)
582,400
CAPEX
(133,900)
(142,300)
Cash from investing activities
(154,400)
(266,400)
Cash from financing activities
331,500
(237,400)
FCF
787,200
403,300
Balance
Cash
302,400
572,000
Long term investments
19,800
14,500
Excess cash
97,860
296,385
Stockholders' equity
6,221,700
5,137,900
Invested Capital
9,244,040
7,179,915
ROIC
22.76%
15.60%
ROCE
7.89%
15.87%
EV
Common stock shares outstanding
125,533
126,707
Price
63.05
-49.48%
124.80
13.57%
Market cap
7,914,856
-49.95%
15,813,034
11.42%
EV
11,867,956
18,674,134
EBITDA
1,000,900
1,406,800
EV/EBITDA
11.86
13.27
Interest
237,200
151,800
Interest/NOPBT
31.64%
12.27%